Induction of steroid sulfatase expression in PC-3 human prostate cancer cells by insulin-like growth factor II

Toxicology Letters

Volumn 223, Issue 2, 2013, Pages 109-115

  Sung, Chul Hoon ^a   Im, Hee Jung ^a   Park, Nahee ^a   Kwon, Yeojung ^a   Shin, Sangyun ^a   Ye, Dong Jin ^a   Cho, Nam Hyeon ^a   Park, Young Shin ^a   Choi, Hyung Kyoon ^a   Kim, Donghak ^b   Chun, Young Jin ^a  

^a Chung Ang University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Akt; Insulin like growth factor II; NF B; PI3 kinase; Steroid sulfatase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BORTEZOMIB; ESTRADIOL; ESTRONE; LUCIFERASE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN B; STERYL SULFATASE; SULFOTRANSFERASE; TESTOSTERONE 17BETA DEHYDROGENASE; WORTMANNIN;

ARTICLE; CANCER CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSIENT TRANSFECTION; WESTERN BLOTTING;

17Β-HYDROXYSTEROID DEHYDROGENASE; AKT; EST; ESTRONE SULFOTRANSFERASE; HSD; IGF; IL-6; INSULIN-LIKE GROWTH FACTOR; INSULIN-LIKE GROWTH FACTOR-II; INTERLEUKIN 6; NBD; NEMO BINDING DOMAIN; NF-ΚB; PI3-KINASE; STEROID SULFATASE; STS; TNF; TUMOR NECROSIS FACTOR;

17-HYDROXYSTEROID DEHYDROGENASES; ANDROSTADIENES; BORONIC ACIDS; CELL LINE, TUMOR; CHROMONES; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LEUPEPTINS; MALE; MORPHOLINES; NF-KAPPA B; NITRILES; PHOSPHATIDYLINOSITOL 3-KINASES; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; PYRAZINES; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; STERYL-SULFATASE; SULFONES; SULFOTRANSFERASES;

EID: 84885808896     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.09.006     Document Type: Article

References (37)

1. Adams J., Garcia M., Rochefort H. Estrogenic effects of physiological concentrations of 5-androstene-3β,17β-diol and its metabolism in MCF7 human breast cancer cells. Cancer Research 1981, 41:4720-4726.
2. Aksoy I.A., Wood T.C., Weinshilboum R. Human liver estrogen sulfotransferase: identification by cDNA cloning and expression. Biochemical and Biophysical Research Communications 1994, 200:1621-1629.
3. Belguise K., Kersual N., Galtier F., Chalbos D. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene 2005, 24:1434-1444.
4. Bennett A., Wilson D.M., Liu F., Nagashima R., Rosenfeld R.G., Hintz R.L. Levels of insulin-like growth factors I and II in human cord blood. Journal of Clinical Endocrinology and Metabolism 1983, 57:609-612.
5. Brookes K.J., Hawi Z., Kirley A., Barry E., Gill M., Kent L. Association of the steroid sulfatase (STS) gene with attention deficit hyperactivity disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2008, 147B:1531-1535.
6. Dao T.L., Hayes C., Libby P.R. Steroid sulfatase activities in human breast tumors. Proceedings of the Society for Experimental Biology and Medicine 1974, 146:381-384.
7. De León D.D., Wilson D.M., Powers M., Rosenfeld R.G. Effects of IGFs and IGF receptor antibodies on the proliferation of breast cancer cells. Growth Factors 1992, 6:327-336.
8. Geisler J., Sasano H., Chen S., Purohit A. Steroid sulfatase inhibitors: promising new tools for breast cancer therapy?. Journal of Steroid Biochemistry and Molecular Biology 2011, 125:39-45.
9. Ghosh D. Mutations in X-linked ichthyosis disrupt the active site structure of estrone/DHEA sulfatase. Biochimica et Biophysica Acta 2004, 1739:1-4.
10. Hernandez-Martin A., Gonzalez-Sarmiento R., De Unamuno P. X-linked ichthyosis: an update. British Journal of Dermatology 1999, 141:617-627.
11. Hughes P.J., Lee J.S., Reiner N.E., Brown G. The vitamin D receptor-mediated activation of phosphatidylinositol 3-kinase (PI3Kα) plays a role in the 1α,25-dihydroxyvitamin D3-stimulated increase in steroid sulphatase activity in myeloid leukaemic cell lines. Journal of Cellular Biochemistry 2008, 103:1551-1572.
12. Hughes P.J., Twist L.E., Durham J., Choudhry M.A., Drayson M., Chandraratna R., Michell R.H., Kirk C.J., Brown G. Up-regulation of steroid sulphatase activity in HL60 promyelocytic cells by retinoids and 1α,25-dihydroxy vitamin D3. Biochemical Journal 2001, 355:361-371.
13. Im H.J., Park N., Kwon Y.J., Shin S., Kim D., Chun Y.J. Bacterial lipopolysaccharides induce steroid sulfatase expression and cell migration through IL-6 pathway in human prostate cancer cells. Biomolecules and Therapeutics 2012, 20:556-561.
14. Kent L., Emerton J., Bhadravathi V., Weisblatt E., Pasco G., Willatt L.R., McMahon R., Yates J.R. X-linked ichthyosis (steroid sulfatase deficiency) is associated with increased risk of attention deficit hyperactivity disorder, autism and social communication deficits. Journal of Medical Genetics 2008, 45:519-524.
15. Kustikova O., Kramerov D., Grigorian M., Berezin V., Bock E., Lukanidin E., Tulchinsky E. Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells. Molecular and Cellular Biology 1998, 18:7095-7105.
16. Lee A.V., Darbre P., King R.J. Processing of IGF-II by human breast cancer cells. Molecular and Cellular Endocrinology 1994, 99:211-220.
17. Li X.M., Alperin E.S., Salido E., Gong Y., Yen P., Shapiro L.J. Characterization of the promoter region of human steroid sulfatase: a gene which escapes X inactivation. Somatic Cell and Molecular Genetics 1996, 22:105-117.
18. Maltais R., Poirier D. Steroid sulfatase inhibitors: a review covering the promising 2000-2010 decade. Steroids 2011, 76:929-948.
19. Mani A.M., Fenwick M.A., Cheng Z., Sharma M.K., Singh D., Wathes D.C. IGF1 induces up-regulation of steroidogenic and apoptotic regulatory genes via activation of phosphatidylinositol-dependent kinase/AKT in bovine granulosa cells. Reproduction 2010, 139:139-151.
20. May M.J., Marienfeld R.B., Ghosh S. Characterization of the IκB-kinase NEMO binding domain. Journal of Biological Chemistry 2002, 277:45992-46000.
21. Naitoh K., Honjo H., Yamamoto T., Urabe M., Ogino Y., Yasumura T., Nambara T. Estrone sulfate and sulfatase activity in human breast cancer and endometrial cancer. Journal of Steroid Biochemistry 1989, 33:1049-1054.
22. Nakamura Y., Suzuki T., Fukuda T., Ito A., Endo M., Moriya T., Arai Y., Sasano H. Steroid sulfatase and estrogen sulfotransferase in human prostate cancer. Prostate 2006, 66:1005-1012.
23. Newman S.P., Purohit A., Ghilchik M.W., Potter B.V., Reed M.J. Regulation of steroid sulphatase expression and activity in breast cancer. Journal of Steroid Biochemistry and Molecular Biology 2000, 75:259-264.
24. O'Dell S.D., Day I.N.M. Molecules in focus. Insulin-like growth factor II (IFG-II). International Journal of Biochemistry and Cell Biology 1998, 30:767-771.
25. Pasqualini J.R., Chetrite G., Blacker C., Feinstein M.C., Delalonde L., Talbi M., Maloche C. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. Journal of Clinical Endocrinology and Metabolism 1996, 81:1460-1464.
26. Pasqualini J.R., Gelly C., Lecerf F. Estrogen sulfates: biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells. Breast Cancer Research and Treatment 1986, 8:233-240.
27. Pierce J.W., Schoenleber R., Jesmok G., Best J., Moore S.A., Collins T., Gerritsen M.E. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. Journal of Biological Chemistry 1997, 272:21096-21103.
28. Purohit A., Chapman O., Duncan L., Reed M.J. Modulation of oestrone sulphatase activity in breast cancer cell lines by growth factors. Journal of Steroid Biochemistry and Molecular Biology 1992, 41:563-566.
29. Purohit A., Foster P.A. Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers. Journal of Endocrinology 2012, 212:99-110.
30. Reed M.J., Purohit A., Woo L.W., Newman S.P., Potter B.V. Steroid sulfatase: molecular biology, regulation, and inhibition. Endocrine Reviews 2005, 26:171-202.
31. Reeve A.E. Role of genomic imprinting in Wilms' tumour and overgrowth disorders. Medical and Pediatric Oncology 1996, 27:470-475.
32. Russell P.J., Bennett S., Stricker P. Growth factor involvement in progression of prostate cancer. Clinical Chemistry 1998, 44:705-723.
33. Samani A.A., Yakar S., LeRoith D., Brodt P. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocrine Reviews 2007, 28:20-47.
34. Shaulian E., Karin E. AP-1 as a regulator of cell life and death. Nature Cell Biology 2002, 4:E131-E136.
35. Suh B.Y., Jung J.J., Park N., Seong C.H., Im H.J., Kwon Y., Kim D., Chun Y.J. Induction of steroid sulfatase expression by tumor necrosis factor-α through phosphatidylinositol 3-kinase/Akt signaling pathway in PC-3 human prostate cancer cells. Experimental and Molecular Medicine 2011, 43:646-652.
36. Utsumi T., Yoshimura N., Takeuchi S., Maruta M., Maeda K., Harada N. Elevated steroid sulfatase expression in breast cancers. Journal of Steroid Biochemistry and Molecular Biology 2000, 73:141-145.
37. Wong S.F., Reimann K., Lai L.C. Effect of transforming growth factor-beta1, insulin-like growth factor-I and insulin-like growth factor-II on cell growth and oestrogen metabolism in human breast cancer cell lines. Pathology 2001, 33:454-459.